Sila Realty Trust , Inc . Q4 2025 Earnings Call Summary

<h3>Strategic Execution and Portfolio Resilience</h3>
<ul>
<li> <p class="yf-1fy9kyt">Transitioned shareholder base to approximately 70% institutional ownership following the first full year as a publicly traded company.</p></li>
<li> <p class="yf-1fy9kyt">Acquired six healthcare facilities in 2025 for $150 million, focusing on modern construction and high-quality tenant sponsorship in the 'Sila mold'.</p></li>
<li> <p class="yf-1fy9kyt">Achieved a 90% retention rate on expiring leases, with non-renewals representing only 0.5% of Annual Base Rent (ABR).</p></li>
<li> <p class="yf-1fy9kyt">Improved tenant credit quality by increasing investment-grade rated tenant guarantors to 40.6% of the portfolio.</p></li>
<li> <p class="yf-1fy9kyt">Successfully transitioned the Fayetteville facility to an investment-grade regional hospital system, reducing exposure to Community Health Systems.</p></li>
<li> <p class="yf-1fy9kyt">Executed strategic dispositions, including the Saginaw facility and pending sales in Nevada and Virginia, to optimize portfolio construction.</p></li>
<li> <p class="yf-1fy9kyt">Maintained high portfolio utilization with 99.9% of properties under triple-net lease structures to ensure durable income streams.</p></li>
</ul>
<h3>2026 Outlook and Growth Strategy</h3>
<ul>
<li> <p class="yf-1fy9kyt">Anticipates 2026 acquisition volume to remain similar to 2025 levels, driven by market conditions and a 24-month buying capacity.</p></li>
<li> <p class="yf-1fy9kyt">Prioritizing internal redevelopment and expansion opportunities which typically yield 150 to 200 basis points higher than market capitalization rates.</p></li>
<li> <p class="yf-1fy9kyt">Targets a leverage range of 4.5x to 5.5x net debt to EBITDAre, providing over $200 million in immediate deployment capacity.</p></li>
<li> <p class="yf-1fy9kyt">Expects the 'Silver Tsunami' demographic shift to drive increased outpatient spending and patient volumes through 2030.</p></li>
<li> <p class="yf-1fy9kyt">Plans to complete the Stoughton facility demolition by the end of Q1 2026, reducing monthly carrying costs from $120,000 to $35,000.</p></li>
</ul>
<h3>Operational Adjustments and Risk Factors</h3>
<ul>
<li> <p class="yf-1fy9kyt">Reported a 5.8% decrease in AFFO per share primarily due to increased interest expense from new swaps entered at the end of 2024.</p></li>
<li> <p class="yf-1fy9kyt">Noted a significant reduction in one-time lease termination fees, dropping from over $6 million in 2024 to less than $300,000 in 2025.</p></li>
<li> <p class="yf-1fy9kyt">Identified a known 2026 conversion of a single-tenant property to multi-tenant, with 40% of the space (0.3% of ABR) requiring re-leasing.</p></li>
<li> <p class="yf-1fy9kyt">Highlighted the acquisition of OneOncology by Cencora, which will provide common control for seven former GenesisCare master leased properties.</p></li>
</ul>
<h3>Q&amp;A Session Insights</h3>
<p>Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. <a href="https://moby.co/get-started?utm_source=yahoo_finance&amp;utm_medium=rss&amp;utm_campaign=bounty&amp;utm_content=mid_article_nvidia">Tap here.</a></p>
<h4>Market pricing and implied cap rate disconnect</h4>
<ul>
<li> <p class="yf-1fy9kyt">Management observes market cap rates for rehab facilities in the 6.75% to 7.5% range and MOB/ASC assets between 6% and 6.5%.</p></li>
<li> <p class="yf-1fy9kyt">Acknowledged the disconnect between the stock's implied 8% cap rate and private market valuations, making management cautious about issuing equity.</p></li>
<li> <p class="yf-1fy9kyt">Indicated that while stock repurchases are a 'tool in the toolbox,' they are hesitant to pull liquidity from the market while building an institutional base.</p></li>
</ul>